Phase II Trial of High-Dose Cisplatin Plus Ifosfamide as First-Line Followed by Carboplatin as Second-Line Treatment in Epithelial Ovarian Carcinoma

By Strauss G.   Lund B.   Hansen M.   Hansen H.H.  

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 66-70

Elsevier

Access to resources Recommend Favorite

A Phase II Study of Dacarbazine, Cisplatin, Interferon- and High-dose Interleukin-2 in 'Poor-risk' Metastatic Melanoma

By Proebstle T.M.   Scheibenbogen C.   Sterry W.   Keilholz U.  

European Journal of Cancer, Vol. 32, Iss. 9, 1996-08 ,pp. : 1530-1533

Elsevier

Access to resources Recommend Favorite

Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide?

By Kasper Bernd  

Supportive Care in Cancer, Vol. 12, Iss. 3, 2004-03 ,pp. : 205-207

Springer Publishing Company

Access to resources Recommend Favorite

High-dose toremifene as first-line treatment of metastatic breast cancer resistant to adjuvant aromatase inhibitor: A multicenter phase II study

By                    

Oncology Letters, Vol. 3, Iss. 1, 2012-01 ,pp. : 61-65

Spandidos Publications

Access to resources Recommend Favorite

Phase II Study of a Short Course of Weekly High-dose Cisplatin Combined with Long-term Oral Etoposide in Metastatic Malignant Melanoma

By Planting A.S.T.   van der Burg M.E.L.   Goey S.H.   Schellens J.H.M.   Vecht C.   de Boer-Dennert M.   Stoter G.   Verweij J.  

European Journal of Cancer, Vol. 32, Iss. 11, 1996-10 ,pp. : 2026-2028

Elsevier

Access to resources Recommend Favorite